Jefferies Raises Price Target on Bristol-Myers Squibb (BMY) Following 3Q

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to Jefferies Raises Price Target on Bristol-Myers Squibb (BMY) Following 3Q

Bristol-Myers Squibb Reports Third Quarter Financial Results

October 27, 2016 6:59 AM EDT

Increases Third Quarter Revenues 21% to $4.9 Billion Posts Third Quarter GAAP EPS of $0.72 and Non-GAAP EPS of $0.77 Achieves Key Regulatory Milestones for Opdivo Positive Advisory Opinion for the Treatment of Classical Hodgkin Lymphoma in Europe Application for Advanced Form of Bladder Cancer Accepted for Priority Review in U.S., Validated in Europe Announces Approval of $3 Billion Share Repurchase Authorization Announces Operating Model Evolution for Sustained Growth... More